The Acute Abdomen

Oct 16, 2016 by in ONCOLOGY Comments Off on The Acute Abdomen

Treatment modality Potential side effects Chemotherapy Bacterial overgrowth Bile acid malabsorption Pancreatic insufficiency Neutropenic enterocolitis Edema, ulceration, atrophy Increased bowel permeability Transmural infection Radiation therapy Radiation enteritis Stricture Inflammation/cell death…

read more

Nutrition

Oct 16, 2016 by in ONCOLOGY Comments Off on Nutrition

Malnutrition or evidence of cachexia present at diagnosis Highly emetogenic chemotherapeutic regimens Treatment regimens associated with severe GI complications such as constipation, diarrhea, loss of appetite, mucositis, enterocolitis (i.e., treatment…

read more

Management of Acute Radiation Side Effects

Oct 16, 2016 by in ONCOLOGY Comments Off on Management of Acute Radiation Side Effects

Organ RT side effect Treatment Level of evidenceb Hematologic Neutropenia Consider G-CSF (see Chap.​ 15 for more detail) 1C Thrombocytopenia Platelet transfusion 1C Anemia Red blood cell transfusion; erythropoietin (EPO)-stimulating…

read more

Nausea and Vomiting

Oct 16, 2016 by in ONCOLOGY Comments Off on Nausea and Vomiting

High risk (>90 % frequency of emesis in the absence of prophylaxis) Altretamine bCytarabine 3 g/m2/dose Procarbazine (oral) bCarboplatin Dacarbazine Streptozocin Carmustine >250 mg/m2 bDactinomycin bThiotepa ≥300 mg/m2 bCisplatin Mechlorethamine bCyclophosphamide…

read more

Thrombotic Disorders

Oct 16, 2016 by in ONCOLOGY Comments Off on Thrombotic Disorders

Clinical scenario Recommendations Level of evidenceb Primary thromboprophylaxis Not recommended (including LMWH, warfarin, FFP) 1B Routine screening with coagulation studies or for thrombophilia not recommended 2C Thrombophilia screening can be…

read more

Hyperleukocytosis

Oct 16, 2016 by in ONCOLOGY Comments Off on Hyperleukocytosis

Disease Potential side effect Treatment Level of evidenceb Acute lymphoblastic leukemia Leukostasis Rapid initiation of chemotherapy 1A Hyperhydration 1C Consider leukapheresis for WBC >400–600 × 109/L if no delay in antileukemic chemotherapy…

read more

Tumor Lysis Syndrome

Oct 16, 2016 by in ONCOLOGY Comments Off on Tumor Lysis Syndrome

Laboratory tumor lysis syndrome (2 or more of the following occurring from 3 days prior up to 7 days after commencement of cytotoxic therapy)  Uric acid ≥8 mg/dL or 25…

read more

Transfusion Support

Oct 16, 2016 by in ONCOLOGY Comments Off on Transfusion Support

Clinical status Description Hemoglobin level for transfusion (g/dL) Level of evidencea Stable Asymptomatic, imminent marrow recovery <7 1C Vital sign changes Tachycardia, tachypnea, hypotension <8 1C Thrombocytopenia Recent or active…

read more
Get Clinical Tree app for offline access